San Diego, CA, United States of America

Vladimir Grigor'evich Kharitonov

USPTO Granted Patents = 3 

Average Co-Inventor Count = 7.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Vladimir Grigor'evich Kharitonov: Innovator in Lipid Nanoparticle Technology

Introduction

Vladimir Grigor'evich Kharitonov is a notable inventor based in San Diego, CA (US). He has made significant contributions to the field of pharmaceutical compositions, particularly focusing on lipid nanoparticles. With a total of 3 patents, Kharitonov's work is paving the way for innovative treatments in respiratory diseases.

Latest Patents

Kharitonov's latest patents include groundbreaking work on lipid nanoparticle compositions and their applications. One of his patents details aerosolized pharmaceutical compositions that comprise aerosol particles made of lipid nanoparticles (LNPs). This innovation provides methods for administering these aerosolized compositions effectively. Another patent focuses on delivering lipid nanoparticles to lung cells in subjects suffering from primary ciliary dyskinesia (PCD). This method involves nebulizing a liquid pharmaceutical composition to create an aerosolized formulation for administration.

Career Highlights

Kharitonov is currently associated with Recode Therapeutics, Inc., where he continues to advance his research in lipid nanoparticle technology. His work is crucial in developing new therapeutic strategies for various respiratory conditions.

Collaborations

Some of Kharitonov's notable coworkers include Sakya Sing Mohapatra and Mirko Hennig. Their collaborative efforts contribute to the innovative research environment at Recode Therapeutics.

Conclusion

Vladimir Grigor'evich Kharitonov is a prominent figure in the field of lipid nanoparticle technology, with a focus on improving pharmaceutical compositions for respiratory diseases. His contributions are essential for the advancement of innovative treatments in this area.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…